Director, Global Compound Market Access Leader, Immunology

At Johnson & Johnson, we believe health is everything.

Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com

Job Function:
Market Access

Job Sub Function:
Health Economics Market Access

Job Category:
People Leader

All Job Posting Locations:
Horsham, Pennsylvania, United States of America

Job Description:

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements.

Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Our Immunology team leads in the development of transformational medicines for immunological disorders and illnesses.

You can influence where medicine is going by restoring health to millions of people living with immune diseases. 

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at https://www.jnj.com/innovative-medicine

 Job Description

Global Commercial Strategy Organization, a group within Janssen Global Services and a member of Johnson & Johnson's family of companies, is recruiting for a Global Compound Market Access Leader for Immunology.

This position will be based in Horsham, PA.

The Global Compound Market Access Leader (CMAL) - Immunology, reporting to the Senior Global Compound Market Access Leader, Immunology – Autoantibody Diseases, has the key leadership role of developing and driving the Market Access strategy for the indication(s) aligned with the global brand strategy for Nipocalimab.

The CMAL provides strategic market access leadership at the indication(s)/brand level, expertly representing market access within Compound Development Team and other global strategy teams, building strong relationships and effective collaboration within the matrix.

In doing so, the CMAL will shape key strategic decisions through input/contributions to Clinical Development and Integrated Evidence Generation Plans to ensure that strategic plans fully meet the needs of market access in key countries.

The CMAL takes a lead in the development of indication/brand value propositions and collaborates through the Extended Market Access Team (EMAT) to support timely, optimal reimbursement in a highly challenging environment across diverse regions with complex and differing needs.

The CMAL must understand the needs of markets and develop appropriate solutions.

Lead the global market access strategy for a set of indications for nipocalimab:


* Drive the Compound Market Access Team (CMAT), which include...